Biological Roles and Mechanisms of Circular RNA in Human Cancers

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2020 Mar 27

PMID 32210574

Citations 89

Authors

Qing Tang

Swei Sunny Hann

Affiliations

Soon will be listed here.

Abstract

Circular RNA (circRNA) is an intriguing class of RNA with covalently closed-loop structure and is highly stable and conservative. As new members of the ncRNAs, the function, mechanism, potential diagnostic biomarker, and therapeutic target have raised increased attention. Most circRNAs are presented with characteristics of abundance, stability, conservatism, and often exhibiting tissue/developmental-stage-specific manner. Over 30,000 circRNAs have been identified with their unique structures to maintain stability more easily than linear RNAs. An increased numbers of circRNAs are dysregulated and involved in several biological processes of malignance, such as tumorigenesis, growth, invasion, metastasis, apoptosis, and vascularization. Emerging evidence suggests that circRNAs play important roles by acting as miRNA sponge or protein scaffolding, autophagy regulators, and interacting with RNA-binding protein (RBP), which may potentially serve as a novel promising biomarker for prevention, diagnosis and therapeutic target for treatment of human cancer with great significance either in scientific research or clinic arena. This review introduces concept, major features of circRNAs, and mainly describes the major biological functions and clinical relevance of circRNAs, as well as expressions and regulatory mechanisms in various types of human cancer, including pathogenesis, mode of action, potential target, signaling regulatory pathways, drug resistance, and therapeutic biomarkers. All of which provide evidence for the potential utilities of circRNAs in the diagnosis and treatment of cancer.

Citing Articles

Mechanistic insights into the role of traditional Chinese medicine in treating gastric cancer.

Chen Z, Yu T, Wang Y, Li J, Zhang B, Zhou L Front Oncol. 2025; 14:1443686.

PMID: 39906672 PMC: 11790455. DOI: 10.3389/fonc.2024.1443686.

Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies.

Anvari S, Nikbakht M, Vaezi M, Amini-Kafiabad S, Ahmadvand M Cancer Cell Int. 2024; 24(1):410.

PMID: 39702293 PMC: 11660508. DOI: 10.1186/s12935-024-03596-8.

Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer.

Lee Y, Kim W, Park E, Lee D, Kim J, Shin H Int J Mol Sci. 2024; 25(8).

PMID: 38674135 PMC: 11050203. DOI: 10.3390/ijms25084548.

CircRNA circRREB1 promotes tumorigenesis and progression of breast cancer by activating Erk1/2 signaling through interacting with GNB4.

Chen H, Wang X, Cheng H, Deng Y, Chen J, Wang B Heliyon. 2024; 10(7):e28785.

PMID: 38617926 PMC: 11015410. DOI: 10.1016/j.heliyon.2024.e28785.

Circ_0061140 Potentiates Clear Cell Renal Cell Carcinoma Progression Via the MicroRNA-126-5p/ADAM9 Axis.

Jia G, Lv D, Ni S Mol Biotechnol. 2023; 66(12):3688-3699.

PMID: 38062234 DOI: 10.1007/s12033-023-00977-8.

References

Ji X, Bosse Y, Landi M, Gui J, Xiao X, Qian D . Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun. 2018; 9(1):3221. PMC: 6089967. DOI: 10.1038/s41467-018-05074-y. View

Zhang M, Xia B, Xu Y, Zhang Y, Xu J, Lou G . Circular RNA (hsa_circ_0051240) promotes cell proliferation, migration and invasion in ovarian cancer through miR-637/KLK4 axis. Artif Cells Nanomed Biotechnol. 2019; 47(1):1224-1233. DOI: 10.1080/21691401.2019.1593999. View

Lan X, Cao J, Xu J, Chen C, Zheng C, Wang J . Decreased expression of hsa_circ_0137287 predicts aggressive clinicopathologic characteristics in papillary thyroid carcinoma. J Clin Lab Anal. 2018; 32(8):e22573. PMC: 6817135. DOI: 10.1002/jcla.22573. View

Huang C, Deng H, Wang Y, Jiang H, Xu R, Zhu X . Circular RNA circABCC4 as the ceRNA of miR-1182 facilitates prostate cancer progression by promoting FOXP4 expression. J Cell Mol Med. 2019; 23(9):6112-6119. PMC: 6714494. DOI: 10.1111/jcmm.14477. View

Xiong W, Ai Y, Li Y, Ye Q, Chen Z, Qin J . Microarray Analysis of Circular RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells. Biomed Res Int. 2017; 2017:8421614. PMC: 5471554. DOI: 10.1155/2017/8421614. View

Pan H, Tang L, Jiang H, Li X, Wang R, Gao J . Enhanced expression of circ_0000267 in hepatocellular carcinoma indicates poor prognosis and facilitates cell progression by sponging miR-646. J Cell Biochem. 2019; 120(7):11350-11357. DOI: 10.1002/jcb.28411. View

Yang R, Xing L, Zheng X, Sun Y, Wang X, Chen J . The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 2019; 18(1):4. PMC: 6325825. DOI: 10.1186/s12943-018-0933-7. View

Chi G, Xu D, Zhang B, Yang F . Matrine induces apoptosis and autophagy of glioma cell line U251 by regulation of circRNA-104075/BCL-9. Chem Biol Interact. 2019; 308:198-205. DOI: 10.1016/j.cbi.2019.05.030. View

Sang Y, Chen B, Song X, Li Y, Liang Y, Han D . circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer. Mol Ther. 2019; 27(9):1638-1652. PMC: 6731174. DOI: 10.1016/j.ymthe.2019.05.011. View

10.

Feng Z, Meng S, Zhou H, Xu Z, Tang Y, Li P . Functions and Potential Applications of Circular RNAs in Cancer Stem Cells. Front Oncol. 2019; 9:500. PMC: 6584801. DOI: 10.3389/fonc.2019.00500. View

11.

Tan S, Gou Q, Pu W, Guo C, Yang Y, Wu K . Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for non-small cell lung cancer. Cell Res. 2018; 28(6):693-695. PMC: 5993747. DOI: 10.1038/s41422-018-0033-7. View

12.

Yang C, Wu S, Wu X, Zhou X, Jin S, Jiang H . Silencing circular RNA UVRAG inhibits bladder cancer growth and metastasis by targeting the microRNA-223/fibroblast growth factor receptor 2 axis. Cancer Sci. 2018; 110(1):99-106. PMC: 6317955. DOI: 10.1111/cas.13857. View

13.

Li Q, Liu Y, Chen S, Zong Z, Du Y, Sheng X . circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge. Biomed Pharmacother. 2019; 114:108832. DOI: 10.1016/j.biopha.2019.108832. View

14.

Zeng K, Chen X, Xu M, Liu X, Hu X, Xu T . CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell Death Dis. 2018; 9(4):417. PMC: 5856798. DOI: 10.1038/s41419-018-0454-8. View

15.

Liu Y, Dong Y, Zhao L, Su L, Luo J . Circular RNA‑MTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4/Eg5 axis. Int J Oncol. 2018; 53(4):1752-1762. DOI: 10.3892/ijo.2018.4485. View

16.

Fang J, Hong H, Xue X, Zhu X, Jiang L, Qin M . A novel circular RNA, circFAT1(e2), inhibits gastric cancer progression by targeting miR-548g in the cytoplasm and interacting with YBX1 in the nucleus. Cancer Lett. 2018; 442:222-232. DOI: 10.1016/j.canlet.2018.10.040. View

17.

Wang X, Zhu X, Zhang H, Wei S, Chen Y, Chen Y . Increased circular RNA hsa_circ_0012673 acts as a sponge of miR-22 to promote lung adenocarcinoma proliferation. Biochem Biophys Res Commun. 2018; 496(4):1069-1075. DOI: 10.1016/j.bbrc.2018.01.126. View

18.

Ping L, Jian-Jun C, Chu-Shu L, Guang-Hua L, Ming Z . High circ_100053 predicts a poor outcome for chronic myeloid leukemia and is involved in imatinib resistance. Oncol Res. 2019; . DOI: 10.3727/096504018X15412701483326. View

19.

Gong Y, Mao J, Wu D, Wang X, Li L, Zhu L . Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6. Cancer Cell Int. 2018; 18:116. PMC: 6090603. DOI: 10.1186/s12935-018-0602-3. View

20.

Li Z, Huang C, Bao C, Chen L, Lin M, Wang X . Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015; 22(3):256-64. DOI: 10.1038/nsmb.2959. View